American Society of Hematology
164 old videos with fewer than 5,000 views from this channel.
-
6:24
Mogamulizumab May Be Effective in Relapsed/Refractory T-Cell Leukemia
-
2:01
2017 Highlights of ASH® in North America
-
3:54
Author Voices: Catherine Badens, PharmD, PhD
-
4:01
Author Voices: Peter Johnson, MA, MD, FRCP
-
4:53
The ASH Agenda for Hematology Research: Genomic Profiling
-
5:28
How I Treat Relapsed/Refractory Multiple Myeloma - Kenneth Anderson, MD
-
6:56
Joseph M. Connors, MD: Optimizing Therapy, Minimizing Toxicity in Hodgkin Lymphoma
-
5:31
Aziz Nazha, MD: How Do TP53 Mutation Characteristics Affect MDS Outcomes?
-
4:28
Conversations with Innovators: Jennifer R. Brown, MD, PhD
-
1:37
Blood Advances – Journal Highlights
-
4:10
Stephen M. Ansell, MD, PhD: Nivolumab Moves to Hematology
-
7:10
Joan C. Gill, MD: New Recombinant Factors for von Willebrand Disease
-
4:59
John Mascarenhas, MD, MS: Continuing to Evaluate Pacritinib for Myelofibrosis
-
6:21
Sattva S. Neelapu, MD: Encouraging Results for CAR T-Cells in Refractory DLBCL
-
10:12
Not Just CRISPR: Changing Biology Through Gene-Editing
-
8:35
Steven Pipe, MD: Changing the Delivery of Bleeding Prevention for Hemophilia Patients
-
9:39
Alexander Perl, MD: The New FLT3 Inhibitor Gilteritinib is “Well-Tolerated” in AML
-
6:24
Crystal Mackall, MD: Passing the Checkpoint With New Approaches to Immunotherapy
-
6:45
Kenneth Ataga, MD: Crizanlizumab: A New Option for Managing Sickle Cell-Related Pain Crises?
-
3:47
Debut of Blood Advances, ASH's New Medical Journal
-
3:12
Man on the Street with Dr. Mikkael Sekeres
-
3:02
Press Briefings at the 2016 ASH Annual Meeting
-
2:03
What Impact Has Attending the ASH Annual Meeting Had On Your Career?
-
5:54
2016 ASH Annual Meeting: Day 1 Highlights